Gemmus Pharma
San Francisco, US
Founders & leadership
CD
Christopher DunnExecutive
WG
William GuilfordExecutive
WH
William HolsteinExecutive
DF
Daryl FauldsExecutive
Board
MR
Marc RubinBoard director
LM
Larry MillerBoard director
Reported raises · per SEC filings
Form D private placements$3.3M disclosed across 1 round · 2014
▶$3.3MraisedJun 2014 · 22 investors · PharmaceuticalsRule 506(b)
▶$3.3MraisedJun 2014 · 22 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Christopher DunnDirector
- Marc RubinDirector
- William GuilfordExecutive Officer, Director
- William HolsteinExecutive Officer
- Larry MillerDirector
- Daryl FauldsExecutive Officer, Director
- Offering amount
- $3.3M
- Amount sold
- $3.3M
- First sale
- Apr 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Gemmus Pharma raised?
- Gemmus Pharma has disclosed $3.3M raised across 1 round.
- Where is Gemmus Pharma headquartered?
- Gemmus Pharma is headquartered in San Francisco, US.